Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s00059-020-04951-x

http://scihub22266oqcxt.onion/10.1007/s00059-020-04951-x
suck pdf from google scholar
32514587!7278757!32514587
unlimited free pdf from europmc32514587    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32514587      Herz 2020 ; 45 (7): 619-625
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Onkokardiologie: Neue Herausforderungen, neue Moglichkeiten #MMPMID32514587
  • Michel L; Schadendorf D; Rassaf T
  • Herz 2020[Nov]; 45 (7): 619-625 PMID32514587show ga
  • Patients with cancer are at a higher risk of cardiovascular disease, which contributes to significant morbidity and mortality. The rapid progress in the field of oncological treatments has led to a steady increase in long-term cancer survivors. Care for cardiovascular complications is therefore becoming increasingly important. In addition, the establishment of new oncological therapies has resulted in the identification of previously unknown cardiovascular side effects. Oncocardiology aims to detect and treat cardiovascular diseases associated with cancer and cancer therapy. Continuous scientific, clinical, and structural developments are necessary as the basis for the best care of the growing number of affected patients. This review summarizes current developments in the field of oncocardiology with regard to advances in cancer therapy and challenges in clinical oncocardiology work. Cardiovascular side effects by targeted cancer therapies are characterized and recent advances in the field of cardiovascular diagnostics are outlined. Developments to better integrate oncocardiology into the medical care system and perspectives for modern, patient-oriented care are shown. In light of the coronavirus disease 2019 (COVID-19) pandemic, current challenges and opportunities are highlighted. The relevance of profitable further advances in oncocardiology including standardized guidelines and educational programs is delineated as a mandatory requirement for the successful development of oncocardiology.
  • |*Cardiovascular Diseases/diagnosis/epidemiology/therapy[MESH]
  • |*Neoplasms/diagnosis/epidemiology/therapy[MESH]
  • |Antineoplastic Agents/adverse effects[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |Cardiotoxicity/diagnosis[MESH]
  • |Coronavirus Infections[MESH]
  • |Humans[MESH]
  • |Medical Oncology/*trends[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box